Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Strasser-Fuchs

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Der Nervenarzt|June 2, 1998
[Intravenous immunoglobulins in therapy of intermittent multiple sclerosis. An update]F Fazekas, S Strasser-Fuchs, H P Hartung
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 8, 2007
Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?S Strasser-Fuchs, C Enzinger, S Ropele, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 1, 1991
[Acquired naevus flammeus (Fegeler syndrome)]J T Kainz, H P Soyer, S Strasser-Fuchs, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2001
The Austrian Immunoglobulin in MS (AIMS) study: final analysisS Strasser-Fuchs, F Fazekas, F Deisenhammer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosisF Fazekas, S Ropele, C Enzinger, et al.
Lancet (London, England)|March 1, 1997
Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study GroupF Fazekas, F Deisenhammer, S Strasser-Fuchs, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 1, 1997
Treatment effects of monthly intravenous immunoglobulin on patients with relapsing-remitting multiple sclerosis: further analyses of the Austrian Immunoglobulin in MS studyF Fazekas, F Deisenhammer, S Strasser-Fuchs, et al.
Journal of the Neurological Sciences|May 23, 1998
Roussy-Lévy syndrome is a phenotypic variant of Charcot-Marie-Tooth syndrome IA associated with a duplication on chromosome 17p11.2M Auer-Grumbach, S Strasser-Fuchs, K Wagner, et al.
Der Nervenarzt|February 1, 1996
[Charcot-Marie-Tooth syndrome. Clinico-genetic correlation in an affected family]M Auer-Grumbach, K Wagner, S Strasser-Fuchs, et al.
Neurology|November 26, 2003
Late onset Charcot-Marie-Tooth 2 syndrome caused by two novel mutations in the MPZ geneM Auer-Grumbach, S Strasser-Fuchs, T Robl, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Der Nervenarzt|June 2, 1998
[Intravenous immunoglobulins in therapy of intermittent multiple sclerosis. An update]F Fazekas, S Strasser-Fuchs, H P Hartung
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 8, 2007
Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?S Strasser-Fuchs, C Enzinger, S Ropele, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 1, 1991
[Acquired naevus flammeus (Fegeler syndrome)]J T Kainz, H P Soyer, S Strasser-Fuchs, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2001
The Austrian Immunoglobulin in MS (AIMS) study: final analysisS Strasser-Fuchs, F Fazekas, F Deisenhammer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosisF Fazekas, S Ropele, C Enzinger, et al.
Lancet (London, England)|March 1, 1997
Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study GroupF Fazekas, F Deisenhammer, S Strasser-Fuchs, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 1, 1997
Treatment effects of monthly intravenous immunoglobulin on patients with relapsing-remitting multiple sclerosis: further analyses of the Austrian Immunoglobulin in MS studyF Fazekas, F Deisenhammer, S Strasser-Fuchs, et al.
Journal of the Neurological Sciences|May 23, 1998
Roussy-Lévy syndrome is a phenotypic variant of Charcot-Marie-Tooth syndrome IA associated with a duplication on chromosome 17p11.2M Auer-Grumbach, S Strasser-Fuchs, K Wagner, et al.
Der Nervenarzt|February 1, 1996
[Charcot-Marie-Tooth syndrome. Clinico-genetic correlation in an affected family]M Auer-Grumbach, K Wagner, S Strasser-Fuchs, et al.
Neurology|November 26, 2003
Late onset Charcot-Marie-Tooth 2 syndrome caused by two novel mutations in the MPZ geneM Auer-Grumbach, S Strasser-Fuchs, T Robl, et al.
Pageof 3